Investors are risking future disappointment by paying high for a stock with limited growth expectations. The company's poor earnings outlook isn't affecting its P/E as much as anticipated, suggesting current prices may be unreasonable.
China Shineway Pharmaceutical Group's low P/E ratio may be due to market expectations of limited future growth. Investors accept the low P/E, conceding future earnings probably won't provide any pleasant surprises.
The raw rate of earnings growth and significant insider holdings indicate a bright future for China Shineway Pharmaceutical Group. These factors make it a company worth keeping on the watchlist for potential investors.
By looking into Hong Kong Pharma stocks, I have stumbled on$SHINEWAY PHARM (02877.HK)$http://www.aastocks.com/en/stocks/quote/quick-quote.aspx?symbol=02877and these are the reasons I have bought it: - the company has no debt - the current price of a stock is 7.75HKD, while the company had 6.0HKD in cash according to the last financial report:http://api.aconnect.com.hk/Attachment/68080. As the ex-dividend date passed, the company should have at least 71% of its market cap in cash. Unbelievable. - in that financial report, the company had a very good first half of 2021. - over the past 5 years, the company has increased cash values per year and is profitable, even with the current price it trades approximately at its book value, while at this time PE TTM is 13.047. - the company raised its dividend and made a statement that it plans of increasing the dividends in the future, and the current yield TTM is 9.4%. Sounds pretty good TBH$Hang Seng Index (800000.HK)$
An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data. An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data.
SHINEWAY PHARM Stock Forum
- the company has no debt
- the current price of a stock is 7.75HKD, while the company had 6.0HKD in cash according to the last financial report: http://api.aconnect.com.hk/Attachment/68080 . As the ex-dividend date passed, the company should have at least 71% of its market cap in cash. Unbelievable.
- in that financial report, the company had a very good first half of 2021.
- over the past 5 years, the company has increased cash values per year and is profitable, even with the current price it trades approximately at its book value, while at this time PE TTM is 13.047.
- the company raised its dividend and made a statement that it plans of increasing the dividends in the future, and the current yield TTM is 9.4%.
Sounds pretty good TBH $Hang Seng Index (800000.HK)$
No comment yet